NCT02149888View on ClinicalTrials.gov

PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
HIVHuman Immunodeficiency Virus
Interventions
DRUG

Tenofovir/emtricitabine

Once daily Tenofovir/emtricitabine (Truvada®)

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

Sponsors
All Listed Sponsors
collaborator

Hassle Free Clinic

UNKNOWN

collaborator

Maple Leaf Research

OTHER

collaborator

Toronto Metropolitan University

OTHER

collaborator

AIDS Committee of Toronto

OTHER

collaborator

Canadian AIDS Treatment Information Exchange

UNKNOWN

collaborator

Gilead Sciences

INDUSTRY

lead

Unity Health Toronto

OTHER